Get started
Author

Rodney Pollard

Observed names: Pollard, R. P., Pollard, R. P. E., R P E Pollard, R. Pollard, R.P.E. Pollard, RODNEY P.E. POLLARD, Rodney P E Pollard, Rodney P Pollard, Rodney PE Pollard, Rodney Paul Edward Pollard
OpenAlex ID: A5113523730
Preclinical validation of salivary biomarkers for primary Sjögren's syndrome
2010 · Shen Hu, Kai Gao, et al. · Arthritis Care & Research · 126
Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment
2016 · Konstantina Delli, Erlin A Haacke, et al. · Annals of the Rheumatic Diseases · 100
Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study
2011 · RODNEY P.E. POLLARD, JUSTIN PIJPE, et al. · The Journal of Rheumatology · 91
PDF
Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjögren's syndrome: data from a placebo-controlled clinical trial
2012 · Rodney P E Pollard, Wayel H Abdulahad, et al. · Annals of the Rheumatic Diseases · 78
Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model
2012 · Steve Horvath, Abu NM Nazmul-Hossain, et al. · Arthritis Research & Therapy · 71
PDF
Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy
2012 · Nishath Hamza, Hendrika Bootsma, et al. · Annals of the Rheumatic Diseases · 60
Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjögren's syndrome
2013 · R P E Pollard, W H Abdulahad, et al. · Annals of the Rheumatic Diseases · 40
In primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRI
2016 · Konstantina Delli, Erlin A Haacke, et al. · Annals of the Rheumatic Diseases · 14
PDF
Towards personalized treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment
2015 · F. Spijkervet, K. Delli, et al. · International Journal of Oral and Maxillofacial Surgery · 1
Baseline Characteristics of Parotid Gland Histopathololgy Predict Responsiveness of Patients with Primary Sjogren's Syndrome to Rituximab Treatment
2015 · Delli, K.; id_orcid 0000-0003-3115-3977, Haacke, E. A., et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
B cell targeting in Sjögren's syndrome : clues to pathogenesis
2013 · Rodney Paul Edward Pollard · University of Groningen research database (University of Groningen / Centre for Information Technology)
Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial
2012 · Spijkervet, F. K. L., Pollard, R. P. E., et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
SAT0190 Reduction of serum immunoglobulin free light chains upon rituximab (anti-CD20) treatment correlates with decreased disease activity in patients with primary sjögren's syndrome
2012 · D.M. Bruining, R.P.E. Pollard, et al. · Annals of the Rheumatic Diseases
APRIL and BAFF Levels After Rituximab Treatment in Patients with Primary Sjogren's Syndrome : A Placebo-Controlled Clinical Trial
2011 · Rodney Pollard, Wayel H. Abdulahad, et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
APRIL and BAFF Levels After Rituximab Treatment in Patients with Primary Sjogren's Syndrome
2011 · Rodney Pollard, Wayel H. Abdulahad, et al. · Arthritis & Rheumatism
Works count: 16
Citation count: 581
H-index: 8
I10-index: 8
Year
Topic
Type